Trial Profile
Effect of inhibition selectivity for sodium/glucose cotransporter on Glomerulotubular regulation of sodium balance and circadian blood pressure rhythm.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Oct 2016
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Tofogliflozin (Primary)
- Indications Diabetic nephropathies; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Oct 2016 New trial record